Want to see IN:FISCHER full AI Analyst Report?
FISCHER Stock Chart & Stats
₹43.67
--
Market closed
₹43.67
--
Day’s Range― - ―
52-Week Range₹29.28 - ₹121.45
Previous CloseN/A
VolumeN/A
Average Volume (3M)60.83K
Market Cap
₹19.35B
Enterprise Value₹27.27B
Total Cash (Recent Filing)₹250.46M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)64.1
Beta0.44
Next Earnings
Nov 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.17%
Share Statistics
EPS (TTM)0.46
Shares Outstanding654,515,440
10 Day Avg. Volume38,166
30 Day Avg. Volume60,828
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)6.83
Price to Sales (P/S)8.52
P/FCF Ratio-20.39
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthThe sharp FY2026 revenue increase indicates substantially greater business scale and market activity than the prior year. If the higher revenue base persists, it can support operating leverage, strengthen the company’s competitive position, and provide a larger platform for future growth.
Margin ExpansionMeaningful expansion in both net and EBIT margins shows that FY2026 growth was accompanied by stronger reported profitability, not merely higher sales. Sustained margins would improve earnings quality, support reinvestment, and increase the company’s ability to absorb operating volatility.
Improved Capital StructureRecent leverage appears manageable relative to the company’s growing equity base, giving Fischer Medical Ventures greater financial flexibility than its earlier capital position. A stronger balance sheet can help fund operations and strategic investment while reducing immediate solvency pressure.
Bears Say
Persistent Cash BurnDeeply negative operating and free cash flow is a durable concern because reported accounting profits are not converting into cash. Continued cash burn can increase reliance on external funding, restrict investment flexibility, and undermine the sustainability of recent earnings if it does not reverse.
Unproven Earnings DurabilityThe latest improvement in revenue and margins follows periods of no revenue and losses, so the business has not yet demonstrated a stable multi-year earnings pattern. This history makes forecasting more difficult and raises the risk that FY2026 performance may not represent normalized operating capability.
Historically Weaker Capital BaseAlthough current leverage is described as manageable, the large increase in debt and earlier negative equity show that the capital structure has changed materially and was previously weak. This history increases execution and financing risk if cash generation remains negative or growth slows.
Fischer Medical Ventures Ltd News
FISCHER FAQ
What was Fischer Medical Ventures Ltd’s price range in the past 12 months?
Fischer Medical Ventures Ltd lowest stock price was ₹29.28 and its highest was ₹121.45 in the past 12 months.
What is Fischer Medical Ventures Ltd’s market cap?
Fischer Medical Ventures Ltd’s market cap is ₹19.35B.
When is Fischer Medical Ventures Ltd’s upcoming earnings report date?
Fischer Medical Ventures Ltd’s upcoming earnings report date is Nov 12, 2026 which is in 26 days.
How were Fischer Medical Ventures Ltd’s earnings last quarter?
Fischer Medical Ventures Ltd released its earnings results on Aug 14, 2026. The company reported ₹0.058 earnings per share for the quarter.
Is Fischer Medical Ventures Ltd overvalued?
According to Wall Street analysts Fischer Medical Ventures Ltd’s price is currently Overvalued.
Does Fischer Medical Ventures Ltd pay dividends?
Fischer Medical Ventures Ltd pays a Annually dividend of ₹0.05 which represents an annual dividend yield of 0.17%. See more information on Fischer Medical Ventures Ltd dividends here
What is Fischer Medical Ventures Ltd’s EPS estimate?
Fischer Medical Ventures Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Fischer Medical Ventures Ltd have?
Fischer Medical Ventures Ltd has 654,515,440 shares outstanding.
What happened to Fischer Medical Ventures Ltd’s price movement after its last earnings report?
Fischer Medical Ventures Ltd reported an EPS of ₹0.058 in its last earnings report. Following the earnings report the stock price went down -0.337%.
Which hedge fund is a major shareholder of Fischer Medical Ventures Ltd?
Currently, no hedge funds are holding shares in IN:FISCHER
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Fischer Medical Ventures Ltd
Fischer Medical Ventures Limited, established in 1993 and headquartered in Chennai, India, is a global provider of medical equipment. The company's operations encompass the manufacturing, distribution, leasing, and maintenance of a wide array of medical devices. Its comprehensive product offerings include advanced diagnostic imaging systems such as MRI and CT scanners; specialized screening tools for cancer and tuberculosis, including handheld x-ray units; and innovative solutions like spincare technology and contactless screening. The portfolio further extends to preventive health kiosks, e-health access points, various software solutions, plant-derived nutraceuticals, mental health solutions, and a range of other preventive diagnostic devices and ancillary medical instruments. The company adopted its current name, Fischer Medical Ventures Limited, in March 2024, having previously operated as Fischer Chemic Limited.
Technical Analysis
Aarti Pharmalabs Limited
―
Marksans Pharma Limited
―
Shilpa Medicare Limited
―
Strides Pharma Science Ltd
―
Thyrocare Technologies Ltd
―